These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33197199)

  • 21. Are empirically-derived subtypes of mild cognitive impairment consistent with conventional subtypes?
    Clark LR; Delano-Wood L; Libon DJ; McDonald CR; Nation DA; Bangen KJ; Jak AJ; Au R; Salmon DP; Bondi MW
    J Int Neuropsychol Soc; 2013 Jul; 19(6):635-45. PubMed ID: 23552486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Everyday cognition scale items that best discriminate between and predict progression from clinically normal to mild cognitive impairment.
    Marshall GA; Zoller AS; Kelly KE; Amariglio RE; Locascio JJ; Johnson KA; Sperling RA; Rentz DM; For The Alzheimer's Disease Neuroimaging Initiative
    Curr Alzheimer Res; 2014; 11(9):853-61. PubMed ID: 25274110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Amyloid-β, Small-vessel Disease, and Neurodegeneration Biomarker Positivity, and Progression to Mild Cognitive Impairment in Cognitively Normal Individuals.
    Nadkarni NK; Tudorascu D; Campbell E; Snitz BE; Cohen AD; Halligan E; Mathis CA; Aizenstein HJ; Klunk WE
    J Gerontol A Biol Sci Med Sci; 2019 Oct; 74(11):1753-1760. PubMed ID: 30957843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioral and psychological symptoms and cognitive decline in patients with amnestic MCI and mild AD: a two-year follow-up study.
    Pocnet C; Antonietti JP; Donati A; Popp J; Rossier J; von Gunten A
    Int Psychogeriatr; 2015 Aug; 27(8):1379-89. PubMed ID: 25592615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of Functional Cognition and Complex Everyday Activities in Older Adults with Mild Cognitive Impairment and Mild Dementia: Validity of the Large Allen's Cognitive Level Screen.
    Wesson J; Clemson L; Crawford JD; Kochan NA; Brodaty H; Reppermund S
    Am J Geriatr Psychiatry; 2017 May; 25(5):471-482. PubMed ID: 28238815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychological Criteria for Mild Cognitive Impairment in the Framingham Heart Study's Old-Old.
    Wong CG; Thomas KR; Edmonds EC; Weigand AJ; Bangen KJ; Eppig JS; Jak AJ; Devine SA; Delano-Wood L; Libon DJ; Edland SD; Au R; Bondi MW
    Dement Geriatr Cogn Disord; 2018; 46(5-6):253-265. PubMed ID: 30391953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for the Utility of Actuarial Neuropsychological Criteria Across the Continuum of Normal Aging, Mild Cognitive Impairment, and Dementia.
    Graves LV; Edmonds EC; Thomas KR; Weigand AJ; Cooper S; Bondi MW
    J Alzheimers Dis; 2020; 78(1):371-386. PubMed ID: 32986674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influencing factors on instrumental activities of daily living functioning in people with mild cognitive disorder - a secondary investigation of cross-sectional data.
    Bruderer-Hofstetter M; Gorus E; Cornelis E; Meichtry A; De Vriendt P
    BMC Geriatr; 2022 Oct; 22(1):791. PubMed ID: 36217106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical and sociopsychological characteristics of older community residents with mild cognitive impairment as assessed by the Japanese version of the Montreal Cognitive Assessment.
    Fujiwara Y; Suzuki H; Kawai H; Hirano H; Yoshida H; Kojima M; Ihara K; Obuchi S
    J Geriatr Psychiatry Neurol; 2013 Dec; 26(4):209-20. PubMed ID: 23920040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia.
    Saxton J; Snitz BE; Lopez OL; Ives DG; Dunn LO; Fitzpatrick A; Carlson MC; Dekosky ST;
    J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):737-43. PubMed ID: 19279031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MCI-to-normal reversion using neuropsychological criteria in the Alzheimer's Disease Neuroimaging Initiative.
    Thomas KR; Edmonds EC; Eppig JS; Wong CG; Weigand AJ; Bangen KJ; Jak AJ; Delano-Wood L; Galasko DR; Salmon DP; Edland SD; Bondi MW;
    Alzheimers Dement; 2019 Oct; 15(10):1322-1332. PubMed ID: 31495605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum.
    Roy K; Pepin LC; Philiossaint M; Lorius N; Becker JA; Locascio JJ; Rentz DM; Sperling RA; Johnson KA; Marshall GA
    J Alzheimers Dis; 2014; 42(1):291-300. PubMed ID: 24898635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing functional status using the IADL-extended scale: results from the HELIAD study.
    Kalligerou F; Fieo R; Paraskevas GP; Zalonis I; Kosmidis MH; Yannakoulia M; Ntanasi E; Dardiotis E; Hadjigeorgiou G; Sakka P; Scarmeas N
    Int Psychogeriatr; 2020 Sep; 32(9):1045-1053. PubMed ID: 31502533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Executive Functions in the Conversion from Mild Cognitive Impairment to Dementia.
    Junquera A; García-Zamora E; Olazarán J; Parra MA; Fernández-Guinea S
    J Alzheimers Dis; 2020; 77(2):641-653. PubMed ID: 32741835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mild Cognitive Impairment and Changes in Everyday Function Over Time: The Importance of Evaluating Both Speed and Accuracy.
    Lassen-Greene CL; Steward K; Okonkwo O; Porter E; Crowe M; Vance DE; Griffith HR; Ball K; Marson DC; Wadley VG
    J Geriatr Psychiatry Neurol; 2017 Jul; 30(4):220-227. PubMed ID: 28639877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mild Cognitive Impairment, Reversion Rates, and Associated Factors: Comparison of Two Diagnostic Approaches.
    Overton M; Sjögren B; Elmståhl S; Rosso A
    J Alzheimers Dis; 2023; 91(2):585-601. PubMed ID: 36463443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trajectories of decline on instrumental activities of daily living prior to dementia in persons with mild cognitive impairment.
    Cloutier S; Chertkow H; Kergoat MJ; Gélinas I; Gauthier S; Belleville S
    Int J Geriatr Psychiatry; 2021 Feb; 36(2):314-323. PubMed ID: 32892375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic Stability of Mild Cognitive Impairment, and Predictors of Reversion to Normal Cognitive Functioning.
    Overton M; Pihlsgård M; Elmståhl S
    Dement Geriatr Cogn Disord; 2019; 48(5-6):317-329. PubMed ID: 32224608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Examining differences in neuropsychiatric symptom factor trajectories in empirically derived mild cognitive impairment subtypes.
    De Vito AN; Calamia M; Weitzner DS; Bernstein JPK;
    Int J Geriatr Psychiatry; 2018 Dec; 33(12):1627-1634. PubMed ID: 30276884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of longitudinal cortical atrophy over 3 years in empirically derived MCI subtypes.
    Edmonds EC; Weigand AJ; Hatton SN; Marshall AJ; Thomas KR; Ayala DA; Bondi MW; McDonald CR;
    Neurology; 2020 Jun; 94(24):e2532-e2544. PubMed ID: 32393648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.